{"title":"基于深度学习的MRI扫描儿童胰腺分割。","authors":"Elif Keles , Merve Yazol , Gorkem Durak , Ziliang Hong , Halil Ertugrul Aktas , Zheyuan Zhang , Linkai Peng , Onkar Susladkar , Necati Guzelyel , Oznur Leman Boyunaga , Cemal Yazici , Mark Lowe , Aliye Uc , Ulas Bagci","doi":"10.1016/j.pan.2025.06.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Our study aimed to evaluate and validate <em>PanSegNet</em><span>, a deep learning (DL) algorithm for pediatric<span> pancreas segmentation on MRI in children with acute pancreatitis (AP), chronic pancreatitis (CP), and healthy controls.</span></span></div></div><div><h3>Methods</h3><div>With IRB approval, we retrospectively collected 84 MRI scans (1.5T/3T Siemens Aera/Verio) from children aged 2–19 years at Gazi University (2015–2024). The dataset includes healthy children as well as patients diagnosed with AP or CP based on clinical criteria. Pediatric and general radiologists manually segmented the pancreas, then confirmed by a senior pediatric radiologist. <em>PanSegNet</em>-generated segmentations were assessed using Dice Similarity Coefficient (DSC) and 95th percentile Hausdorff distance (HD95). Cohen's kappa measured observer agreement.</div></div><div><h3>Results</h3><div>Pancreas MRI T2W scans were obtained from 42 children with AP/CP (mean age: 11.73 ± 3.9 years) and 42 healthy children (mean age: 11.19 ± 4.88 years). <em>PanSegNet</em> achieved DSC scores of 88 % (controls), 81 % (AP), and 80 % (CP), with HD95 values of 3.98 mm (controls), 9.85 mm (AP), and 15.67 mm (CP). Inter-observer kappa was 0.86 (controls), 0.82 (pancreatitis), and intra-observer agreement reached 0.88 and 0.81. Strong agreement was observed between automated and manual volumes (R<sup>2</sup> = 0.85 in controls, 0.77 in diseased), demonstrating clinical reliability.</div></div><div><h3>Conclusion</h3><div><em>PanSegNet</em> represents the first validated deep learning solution for pancreatic MRI segmentation, achieving expert-level performance across healthy and diseased states. This tool, algorithm, along with our annotated dataset, are freely available on <span><span>GitHub</span><svg><path></path></svg></span> and <span><span>OSF</span><svg><path></path></svg></span>, advancing accessible, radiation-free pediatric pancreatic imaging and fostering collaborative research in this underserved domain.</div></div>","PeriodicalId":19976,"journal":{"name":"Pancreatology","volume":"25 5","pages":"Pages 648-657"},"PeriodicalIF":2.7000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pediatric pancreas segmentation from MRI scans with deep learning\",\"authors\":\"Elif Keles , Merve Yazol , Gorkem Durak , Ziliang Hong , Halil Ertugrul Aktas , Zheyuan Zhang , Linkai Peng , Onkar Susladkar , Necati Guzelyel , Oznur Leman Boyunaga , Cemal Yazici , Mark Lowe , Aliye Uc , Ulas Bagci\",\"doi\":\"10.1016/j.pan.2025.06.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Our study aimed to evaluate and validate <em>PanSegNet</em><span>, a deep learning (DL) algorithm for pediatric<span> pancreas segmentation on MRI in children with acute pancreatitis (AP), chronic pancreatitis (CP), and healthy controls.</span></span></div></div><div><h3>Methods</h3><div>With IRB approval, we retrospectively collected 84 MRI scans (1.5T/3T Siemens Aera/Verio) from children aged 2–19 years at Gazi University (2015–2024). The dataset includes healthy children as well as patients diagnosed with AP or CP based on clinical criteria. Pediatric and general radiologists manually segmented the pancreas, then confirmed by a senior pediatric radiologist. <em>PanSegNet</em>-generated segmentations were assessed using Dice Similarity Coefficient (DSC) and 95th percentile Hausdorff distance (HD95). Cohen's kappa measured observer agreement.</div></div><div><h3>Results</h3><div>Pancreas MRI T2W scans were obtained from 42 children with AP/CP (mean age: 11.73 ± 3.9 years) and 42 healthy children (mean age: 11.19 ± 4.88 years). <em>PanSegNet</em> achieved DSC scores of 88 % (controls), 81 % (AP), and 80 % (CP), with HD95 values of 3.98 mm (controls), 9.85 mm (AP), and 15.67 mm (CP). Inter-observer kappa was 0.86 (controls), 0.82 (pancreatitis), and intra-observer agreement reached 0.88 and 0.81. Strong agreement was observed between automated and manual volumes (R<sup>2</sup> = 0.85 in controls, 0.77 in diseased), demonstrating clinical reliability.</div></div><div><h3>Conclusion</h3><div><em>PanSegNet</em> represents the first validated deep learning solution for pancreatic MRI segmentation, achieving expert-level performance across healthy and diseased states. This tool, algorithm, along with our annotated dataset, are freely available on <span><span>GitHub</span><svg><path></path></svg></span> and <span><span>OSF</span><svg><path></path></svg></span>, advancing accessible, radiation-free pediatric pancreatic imaging and fostering collaborative research in this underserved domain.</div></div>\",\"PeriodicalId\":19976,\"journal\":{\"name\":\"Pancreatology\",\"volume\":\"25 5\",\"pages\":\"Pages 648-657\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pancreatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S142439032500119X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pancreatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S142439032500119X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Pediatric pancreas segmentation from MRI scans with deep learning
Objective
Our study aimed to evaluate and validate PanSegNet, a deep learning (DL) algorithm for pediatric pancreas segmentation on MRI in children with acute pancreatitis (AP), chronic pancreatitis (CP), and healthy controls.
Methods
With IRB approval, we retrospectively collected 84 MRI scans (1.5T/3T Siemens Aera/Verio) from children aged 2–19 years at Gazi University (2015–2024). The dataset includes healthy children as well as patients diagnosed with AP or CP based on clinical criteria. Pediatric and general radiologists manually segmented the pancreas, then confirmed by a senior pediatric radiologist. PanSegNet-generated segmentations were assessed using Dice Similarity Coefficient (DSC) and 95th percentile Hausdorff distance (HD95). Cohen's kappa measured observer agreement.
Results
Pancreas MRI T2W scans were obtained from 42 children with AP/CP (mean age: 11.73 ± 3.9 years) and 42 healthy children (mean age: 11.19 ± 4.88 years). PanSegNet achieved DSC scores of 88 % (controls), 81 % (AP), and 80 % (CP), with HD95 values of 3.98 mm (controls), 9.85 mm (AP), and 15.67 mm (CP). Inter-observer kappa was 0.86 (controls), 0.82 (pancreatitis), and intra-observer agreement reached 0.88 and 0.81. Strong agreement was observed between automated and manual volumes (R2 = 0.85 in controls, 0.77 in diseased), demonstrating clinical reliability.
Conclusion
PanSegNet represents the first validated deep learning solution for pancreatic MRI segmentation, achieving expert-level performance across healthy and diseased states. This tool, algorithm, along with our annotated dataset, are freely available on GitHub and OSF, advancing accessible, radiation-free pediatric pancreatic imaging and fostering collaborative research in this underserved domain.
期刊介绍:
Pancreatology is the official journal of the International Association of Pancreatology (IAP), the European Pancreatic Club (EPC) and several national societies and study groups around the world. Dedicated to the understanding and treatment of exocrine as well as endocrine pancreatic disease, this multidisciplinary periodical publishes original basic, translational and clinical pancreatic research from a range of fields including gastroenterology, oncology, surgery, pharmacology, cellular and molecular biology as well as endocrinology, immunology and epidemiology. Readers can expect to gain new insights into pancreatic physiology and into the pathogenesis, diagnosis, therapeutic approaches and prognosis of pancreatic diseases. The journal features original articles, case reports, consensus guidelines and topical, cutting edge reviews, thus representing a source of valuable, novel information for clinical and basic researchers alike.